Literature DB >> 20178887

The use of screening instruments for detecting alcohol and other drug use disorders in first-episode psychosis.

Ragnar Nesvåg1, Elisabeth H Lange, Ann Faerden, Elizabeth Ann Barrett, Björn Emilsson, Petter Andreas Ringen, Ole A Andreassen, Ingrid Melle, Ingrid Agartz.   

Abstract

The high rate of drug abuse among patients with psychosis represents a challenge to clinicians in their treatment of the patients. Powerful screening tools to detect problematic drug use in an early phase of psychotic illness are needed. The aim of the present study was to investigate prevalence of drug use disorders and psychometric properties of the Alcohol Use Disorder Identification Test (AUDIT) and the Drug Use Disorder Identification Test (DUDIT) in 205 first-episode psychosis patients in Oslo, Norway. Internal consistency of the instruments and criterion-based validity as compared to a current DSM-IV diagnosis of abuse or dependence of alcohol or other drugs were analyzed. Fifteen percent of the men and 11% of the women had a DSM-IV diagnosis of alcohol use disorders while 33% of the men and 16% of the women had non-alcohol drug use disorders. The instruments were reliable (Cronbach's alpha above 0.90) and valid (Area under the curve above 0.83). Suitable cut-off scores (sensitivity >0.80 and specificity >0.70) were ten for men and eight for women on AUDIT and three for men and one for women on DUDIT. The results of this study suggest that AUDIT and DUDIT are powerful screening instruments for detecting alcohol and other drug use disorders in patients with first-episode psychosis. Copyright 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20178887     DOI: 10.1016/j.psychres.2010.01.007

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  9 in total

1.  Psychometric characteristics of the Drug Use Disorders Identification Test (DUDIT) and the Drug Use Disorders Identification Test-Extended (DUDIT-E) among young drug users in Hungary.

Authors:  Balázs Matuszka; Erika Bácskai; Anne H Berman; Pál Czobor; Kristina Sinadinovic; József Gerevich
Journal:  Int J Behav Med       Date:  2014-06

2.  Substance use disorders in schizophrenia, bipolar disorder, and depressive illness: a registry-based study.

Authors:  Ragnar Nesvåg; Gun Peggy Knudsen; Inger Johanne Bakken; Anne Høye; Eivind Ystrom; Pål Surén; Anne Reneflot; Camilla Stoltenberg; Ted Reichborn-Kjennerud
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2015-02-14       Impact factor: 4.328

3.  Self-wise, Other-wise, Streetwise (SOS) training: a novel intervention to reduce victimization in dual diagnosis psychiatric patients with substance use disorders: protocol for a randomized controlled trial.

Authors:  Marleen M de Waal; Martijn J Kikkert; Matthijs Blankers; Jack J M Dekker; Anna E Goudriaan
Journal:  BMC Psychiatry       Date:  2015-10-29       Impact factor: 3.630

4.  Collaborative Assessment and Management of Suicidality (CAMS) compared to treatment as usual (TAU) for suicidal patients: study protocol for a randomized controlled trial.

Authors:  Wenche Ryberg; Roar Fosse; Per Henrik Zahl; Inge Brorson; Paul Møller; Nils Inge Landrø; David Jobes
Journal:  Trials       Date:  2016-10-03       Impact factor: 2.279

5.  Basal Exposure Therapy: A New Approach for Treatment-Resistant Patients with Severe and Composite Mental Disorders.

Authors:  Didrik Heggdal; Roar Fosse; Jan Hammer
Journal:  Front Psychiatry       Date:  2016-12-19       Impact factor: 4.157

6.  Psychometric Properties of the Arabic Version of the Drug Use Disorders Identification Test (DUDIT) in Clinical, Prison Inmate, and Student Samples.

Authors:  Anis Sfendla; Btissame Zouini; Dina Lemrani; Anne H Berman; Meftaha Senhaji; Nóra Kerekes
Journal:  Int J Behav Med       Date:  2017-04

7.  Utilization of somatic specialist services among psychiatric immigrant patients: the Norwegian patient registry study.

Authors:  Dawit Shawel Abebe; Jon Ivar Elstad; Lars Lien
Journal:  BMC Health Serv Res       Date:  2018-11-13       Impact factor: 2.655

8.  Effect of Gonadotropin-Releasing Hormone Antagonist on Risk of Committing Child Sexual Abuse in Men With Pedophilic Disorder: A Randomized Clinical Trial.

Authors:  Valdemar Landgren; Kinda Malki; Matteo Bottai; Stefan Arver; Christoffer Rahm
Journal:  JAMA Psychiatry       Date:  2020-09-01       Impact factor: 21.596

9.  Exploring low grade inflammation by soluble urokinase plasminogen activator receptor levels in schizophrenia: a sex-dependent association with depressive symptoms.

Authors:  Therese Torgersen Bigseth; John Abel Engh; Jens Egeland; Eivind Andersen; Ole Andreas Andreassen; Gry Bang-Kittilsen; Ragnhild Sørum Falk; Tom Langerud Holmen; Morten Lindberg; Jon Mordal; Jimmi Nielsen; Nils Eiel Steen; Thor Ueland; Torkel Vang; Mats Fredriksen
Journal:  BMC Psychiatry       Date:  2021-10-26       Impact factor: 3.630

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.